Literature DB >> 2785961

Fixation of Clostridium difficile toxin A and cholera toxin to intestinal brush border membranes from axenic and conventional mice.

F Lucas1, G W Elmer, E Brot-Laroche, G Corthier.   

Abstract

We have tested the in vitro binding of Clostridium difficile toxin A (enterotoxin) and cholera toxin to intestinal brush border membranes prepared from either conventional or axenic mice. Membranes from axenic mice were shown to be saturated at a lower toxin A concentration (at least 2.5 times lower). Because there were no significant differences between membranes from axenic and conventional mice in binding at low toxin A concentrations, the presence of the normal microflora seems to increase the number but not the affinity of brush border membrane receptors on the enterocyte surface. Corroborating the in vitro results, we observed that conventional mice were more sensitive to the pathological effects of toxin A given intragastrically than were axenic mice. In contrast, there was no difference in the binding characteristics of cholera toxin between membranes from conventional and axenic mice. We conclude that the presence of the mouse intestinal bacteria increases the number of C. difficile toxin A intestinal receptors but does not influence cholera toxin receptors.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2785961      PMCID: PMC313339          DOI: 10.1128/iai.57.6.1680-1683.1989

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  18 in total

1.  METHOD FOR ASSAY OF INTESTINAL DISACCHARIDASES.

Authors:  A DAHLQVIST
Journal:  Anal Biochem       Date:  1964-01       Impact factor: 3.365

2.  Clindamycin-associated colitis due to a toxin-producing species of Clostridium in hamsters.

Authors:  J G Bartlett; A B Onderdonk; R L Cisneros; D L Kasper
Journal:  J Infect Dis       Date:  1977-11       Impact factor: 5.226

3.  Experimental reproduction of neonatal diarrhea in young gnotobiotic hares simultaneously associated with Clostridium difficile and other Clostridium strains.

Authors:  J Dabard; F Dubos; L Martinet; R Ducluzeau
Journal:  Infect Immun       Date:  1979-04       Impact factor: 3.441

4.  Evaluation of eight cephalosporins in hamster colitis model.

Authors:  J R Ebright; R Fekety; J Silva; K H Wilson
Journal:  Antimicrob Agents Chemother       Date:  1981-06       Impact factor: 5.191

5.  Comparison of two toxins produced by Clostridium difficile.

Authors:  N S Taylor; G M Thorne; J G Bartlett
Journal:  Infect Immun       Date:  1981-12       Impact factor: 3.441

6.  Clindamycin-induced enterocolitis in hamsters as a model of pseudomembranous colitis in patients.

Authors:  T W Chang; J G Bartlett; S L Gorbach; A B Onderdonk
Journal:  Infect Immun       Date:  1978-05       Impact factor: 3.441

7.  Clostridium difficile and its cytotoxin in feces of patients with antimicrobial agent-associated diarrhea and miscellaneous conditions.

Authors:  W L George; R D Rolfe; S M Finegold
Journal:  J Clin Microbiol       Date:  1982-06       Impact factor: 5.948

Review 8.  Antibiotic-associated pseudomembranous colitis.

Authors:  J G Bartlett
Journal:  Rev Infect Dis       Date:  1979 May-Jun

9.  Clostridium difficile and cytotoxin in feces of patients with antimicrobial agent-associated pseudomembranous colitis.

Authors:  W L George; R D Rolfe; G K Harding; R Klein; C W Putnam; S M Finegold
Journal:  Infection       Date:  1982       Impact factor: 3.553

Review 10.  Role of membrane gangliosides in the binding and action of bacterial toxins.

Authors:  P H Fishman
Journal:  J Membr Biol       Date:  1982       Impact factor: 1.843

View more
  2 in total

1.  Binding kinetics of Clostridium difficile toxins A and B to intestinal brush border membranes from infant and adult hamsters.

Authors:  R D Rolfe
Journal:  Infect Immun       Date:  1991-04       Impact factor: 3.441

2.  Interrelationships between digestive proteolytic activities and production and quantitation of toxins in pseudomembranous colitis induced by Clostridium difficile in gnotobiotic mice.

Authors:  G Corthier; M C Muller; G W Elmer; F Lucas; F Dubos-Ramaré
Journal:  Infect Immun       Date:  1989-12       Impact factor: 3.441

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.